Investors' Chronicle How to pass on wealth, AstraZeneca & Ceres: The Companies and Markets Show
Oct 3, 2025
Julian Hofmann, a seasoned pharmaceuticals expert, shares insights on AstraZeneca's potential blockbuster breast cancer drug, Enhertu, and the company’s strategic shifts. Val Cipriani, a business journalist, discusses the 'Great Wealth Transfer' and offers advice on gifting and inheritance tax, emphasizing planning for family wealth. Finally, Mark Robinson analyzes Ceres Power's disappointing interim results, Bosch’s exit, and the company's pivot toward growing tech markets, specifically data centers. Tune in for valuable insights!
AI Snips
Chapters
Transcript
Episode notes
Astra Harmonises Listings To Access US Capital
- AstraZeneca will convert US ADRs to full shares while keeping UK headquarters and Stockholm listing.
- The move reflects where its commercial and capital opportunities primarily lie: the US market.
Smooth Leadership Handover At GSK
- Emma Walmsley will step down and Luke Miels takes over as GSK CEO on 1 January.
- The handover follows strategic restructuring and leaves Miels tasked with driving the US-focused next phase.
Plan Lifetime Gifts Versus Wills
- Decide whether to gift in life or via your will based on access needs and tax considerations.
- Remember gifts fall outside your estate for inheritance tax if you survive seven years after giving.